Axid AR is first H2 antagonist to provide "complete" heartburn prevention data.
This article was originally published in The Tan Sheet
Executive Summary
AXID AR PACKAGE INSERT INCLUDES "COMPLETE PREVENTION" EFFICACY DATA illustrated by two bar graphs. FDA cleared Whitehall-Robins' Axid AR for OTC marketing on May 9 ("The Tan Sheet" May 13, p. 1). Axid AR is indicated for prevention of heartburn, acid indigestion and sour stomach.